{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:25:51Z","timestamp":1757701551007},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221333-4\"><jats:title>Importance<\/jats:title><jats:p>Cannabis has been proposed as a therapeutic with potential opioid-sparing properties in chronic pain, and its use could theoretically be associated with decreased amounts of opioids used and decreased risk of mortality among individuals prescribed opioids.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221333-5\"><jats:title>Objective<\/jats:title><jats:p>To examine the risks associated with cannabis use among adults prescribed opioid analgesic medications.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221333-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study was conducted among individuals aged 18 years and older who had urine drug screening in 2014 to 2019 and received any prescription opioid in the prior 90 days or long-term opioid therapy (LTOT), defined as more than 84 days of the prior 90 days, through the Veterans Affairs health system. Data were analyzed from November 2020 through March 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221333-7\"><jats:title>Exposures<\/jats:title><jats:p>Biologically verified cannabis use from a urine drug screen.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221333-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcomes were 90-day and 180-day all-cause mortality. A composite outcome of all-cause emergency department (ED) visits, all-cause hospitalization, or all-cause mortality was a secondary outcome. Weights based on the propensity score were used to reduce confounding, and hazard ratios [HRs] were estimated using Cox proportional hazards regression models. Analyses were conducted among the overall sample of patients who received any prescription opioid in the prior 90 days and were repeated among those who received LTOT. Analyses were repeated among adults aged 65 years and older.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221333-9\"><jats:title>Results<\/jats:title><jats:p>Among 297\u202f620 adults treated with opioids, 30\u202f514 individuals used cannabis (mean [SE] age, 57.8 [10.5] years; 28\u202f784 [94.3%] men) and 267\u202f106 adults did not (mean [SE] age, 62.3 [12.3] years; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001; 247\u202f684 [92.7%] men; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Among all patients, cannabis use was not associated with increased all-cause mortality at 90 days (HR, 1.07; 95% CI, 0.92-1.22) or 180 days (HR, 1.00; 95% CI, 0.90-1.10) but was associated with an increased hazard of the composite outcome at 90 days (HR, 1.05; 95% CI, 1.01-1.07) and 180 days (HR, 1.04; 95% CI, 1.01-1.06). Among 181\u202f096 adults receiving LTOT, cannabis use was not associated with increased risk of all-cause mortality at 90 or 180 days but was associated with an increased hazard of the composite outcome at 90 days (HR, 1.05; 95% CI, 1.02-1.09) and 180 days (HR, 1.05; 95% CI, 1.02-1.09). Among 77\u202f791 adults aged 65 years and older receiving LTOT, cannabis use was associated with increased 90-day mortality (HR, 1.55; 95% CI, 1.17-2.04).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221333-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This study found that cannabis use among adults receiving opioid analgesic medications was not associated with any change in mortality risk but was associated with a small increased risk of adverse outcomes and that short-term risks were higher among older adults receiving LTOT.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.47201","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:31:34Z","timestamp":1671208294000},"page":"e2247201","source":"Crossref","is-referenced-by-count":4,"title":["Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids"],"prefix":"10.1001","volume":"5","author":[{"given":"Salomeh","family":"Keyhani","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"},{"name":"San Francisco VA Medical Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Leonard","sequence":"additional","affiliation":[{"name":"Northern California Institute for Research and Education, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Byers","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"},{"name":"San Francisco VA Medical Center, San Francisco, California"},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tauheed","family":"Zaman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco"},{"name":"Addiction Recovery and Treatments Services, San Francisco VA Health Care System, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Krebs","sequence":"additional","affiliation":[{"name":"Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, Minneapolis, Minnesota"},{"name":"Department of Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Moss-Vazquez","sequence":"additional","affiliation":[{"name":"Northern California Institute for Research and Education, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Austin","sequence":"additional","affiliation":[{"name":"Richard L. Roudebush VA Medical Center, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Sandbrink","sequence":"additional","affiliation":[{"name":"National Pain Management, Opioid Safety and Prescription Drug Monitoring Program, Veterans Health Administration, Washington, District of Columbia"},{"name":"Department of Neurology, George Washington University, Washington District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn M.","family":"Bravata","sequence":"additional","affiliation":[{"name":"Richard L. Roudebush VA Medical Center, Indianapolis, Indiana"},{"name":"Departments of Medicine and Neurology, Indiana University School of Medicine, Indianapolis"},{"name":"Regenstreif Institute, Indianapolis Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"issue":"24","key":"zoi221333r1","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis.","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"zoi221333r2","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.36076\/ppj","article-title":"Opioid complications and side effects.","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"issue":"3","key":"zoi221333r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193706","article-title":"A search algorithm for identifying likely users and non-users of marijuana from the free text of the electronic medical record.","volume":"13","author":"Keyhani","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"zoi221333r4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21452","article-title":"Medical cannabis use reduces opioid prescriptions in patients with chronic back pain.","volume":"14","author":"Greis","year":"2022","journal-title":"Cureus"},{"issue":"7","key":"zoi221333r5","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1016\/S2468-2667(18)30110-5","article-title":"Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.","volume":"3","author":"Campbell","year":"2018","journal-title":"Lancet Public Health"},{"key":"zoi221333r7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11606-020-06258-3","article-title":"Opioid prescribing and opioid risk mitigation strategies in the Veterans Health Administration.","volume":"35","author":"Sandbrink","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi221333r9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MLR.0b013e31827da95a","article-title":"Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration.","volume":"51","author":"Wang","year":"2013","journal-title":"Med Care"},{"issue":"12","key":"zoi221333r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28557","article-title":"Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015.","volume":"3","author":"Xu","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi221333r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study.","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"zoi221333r14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jadohealth.2019.07.024","article-title":"Cannabis use is an independent predictor for acute myocardial infarction related hospitalization in younger population.","volume":"66","author":"Patel","year":"2020","journal-title":"J Adolesc Health"},{"issue":"1","key":"zoi221333r15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001216","article-title":"Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study.","volume":"9","author":"Vozoris","year":"2022","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"zoi221333r17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"16","key":"zoi221333r20","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/sim.v32.16","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios.","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med"},{"key":"zoi221333r21","doi-asserted-by":"publisher","first-page":"m4957","DOI":"10.1136\/bmj.m4957","article-title":"Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.","volume":"372","author":"Hsu","year":"2021","journal-title":"BMJ"},{"key":"zoi221333r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2019.102273","article-title":"The impact of cannabis access laws on opioid prescribing.","volume":"69","author":"McMichael","year":"2020","journal-title":"J Health Econ"},{"issue":"11","key":"zoi221333r23","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2105\/AJPH.2017.304059","article-title":"Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015.","volume":"107","author":"Livingston","year":"2017","journal-title":"Am J Public Health"},{"issue":"10","key":"zoi221333r24","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"zoi221333r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103449","article-title":"Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011.","volume":"99","author":"Kim","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"2","key":"zoi221333r27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/QAI.0000000000001998","article-title":"Marijuana use is not associated with changes in opioid prescriptions or pain severity among people living with HIV and chronic pain.","volume":"81","author":"Merlin","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"zoi221333r28","doi-asserted-by":"publisher","first-page":"e2145691","DOI":"10.1001\/jamanetworkopen.2021.45691","article-title":"Factors associated with opioid overdose after an initial opioid prescription.","volume":"5","author":"Weiner","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi221333r29","doi-asserted-by":"publisher","first-page":"e2031647","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States.","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"21","key":"zoi221333r30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons.","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"12","key":"zoi221333r31","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2105\/AJPH.80.12.1467","article-title":"Benzodiazepine tranquilizers and the risk of accidental injury.","volume":"80","author":"Oster","year":"1990","journal-title":"Am J Public Health"},{"issue":"11","key":"zoi221333r32","doi-asserted-by":"publisher","first-page":"e2136571","DOI":"10.1001\/jamanetworkopen.2021.36571","article-title":"Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US.","volume":"4","author":"Jeffers","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi221333r33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems.","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"zoi221333r34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"8","key":"zoi221333r35","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1111\/add.v116.8","article-title":"Cannabis use and co-use in tobacco smokers and non-smokers: prevalence and associations with mental health in a cross-sectional, nationally representative sample of adults in Great Britain, 2020.","volume":"116","author":"Hindocha","year":"2021","journal-title":"Addiction"},{"issue":"4","key":"zoi221333r36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1017\/S1041610215001738","article-title":"Relationship between marijuana and other illicit drug use and depression\/suicidal thoughts among late middle-aged and older adults.","volume":"28","author":"Choi","year":"2016","journal-title":"Int Psychogeriatr"},{"issue":"11","key":"zoi221333r37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jama.2017.12882","article-title":"Carotid endarterectomy and carotid artery stenting in the US Medicare population, 1999-2014.","volume":"318","author":"Lichtman","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"zoi221333r38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1077558715617382","article-title":"Do veterans health administration enrollees generalize to other populations?","volume":"73","author":"Wong","year":"2016","journal-title":"Med Care Res Rev"},{"key":"zoi221333r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2020.152188","article-title":"Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users.","volume":"102","author":"Turna","year":"2020","journal-title":"Compr Psychiatry"},{"key":"zoi221333r40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drugalcdep.2018.11.009","article-title":"Use of marijuana exclusively for medical purposes.","volume":"195","author":"Wall","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"zoi221333r19","volume-title":"CDC FY 2004 Performance Plan Appendix D: Data Verification and Validation","author":"Centers for Disease Control and Prevention","year":"2004"},{"key":"zoi221333r26","doi-asserted-by":"crossref","DOI":"10.3386\/w29802","volume-title":"Working Paper 29802: Marijuana Legalization and Opioid Deaths","author":"Mathur","year":"2022"},{"key":"zoi221333r6","unstructured":"Cox? GR. VHA directive 1005: informed consent for long-term opioid therapy for pain. Department of Veterans Affairs. Accessed November 10, 2022. https:\/\/www.va.gov\/vhapublications\/ViewPublication.asp?pub_ID=8822"},{"key":"zoi221333r8","unstructured":"DuVall? S, Scehnet? J. Introduction to the VA COVID-19 shared data resource and its use for research. US Department of Veterans Affairs. Accessed November 10, 2022. https:\/\/www.hsrd.research.va.gov\/cyberseminars\/catalog-upcoming-session.cfm?UID=3810"},{"key":"zoi221333r10","unstructured":"Health Services Research & Development. Corporate data warehouse (CDW). US Department of Veterans Affairs. Accessed November 10, 2022. https:\/\/www.hsrd.research.va.gov\/for_researchers\/vinci\/cdw.cfm"},{"key":"zoi221333r11","unstructured":"VA information resource center. US Department of Veterans Affairs. Accessed March 16, 2022. https:\/\/www.virec.research.va.gov\/"},{"key":"zoi221333r16","unstructured":"VA priority groups. US Department of Veterans Affairs. Accessed March 30, 2022. https:\/\/www.va.gov\/health-care\/eligibility\/priority-groups\/"},{"key":"zoi221333r18","unstructured":"Barnett? PG, Chow? A, Flores? NE. Technical report 28: using tobacco health factors data for VA health services research. VA Palo Alto Health Economics Resource Center. Accessed April 29, 2021. https:\/\/www.herc.research.va.gov\/files\/RPRT_768.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799636\/keyhani_2022_oi_221333_1670604896.29716.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:31:42Z","timestamp":1671208302000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.47201","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}